Purchases and Sales Made in Q1 2022 in Avalo Therapeutics, Inc. (AVTX)
This table provides information about the institutional ownership of Avalo Therapeutics, Inc. (AVTX) during Q1 2022. The information is specifically focused on institutions that hold shares of Avalo Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 12, 2022
Q1 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-36.1K- 0.95% |
$273K - $784K
|
3.77M
$36.6M
|
|
|
May 02, 2022
Q1 2022
|
Simplex Trading, LLC
|
SELL
|
- |
-55.9KClosed |
$423K - $1.21M
|
0
$0
|
|
|
May 13, 2022
Q1 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-79.1K- 51.24% |
$599K - $1.72M
|
75.3K
$733K
|
|
|
May 16, 2022
Q1 2022
|
Aqr Capital Management LLC
Greenwich, CT |
SELL
|
- |
-91.6KClosed |
$693K - $1.99M
|
0
$0
|
|
|
May 16, 2022
Q1 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-160K- 23.4% |
$1.21M - $3.48M
|
525K
$5.11M
|
|
|
May 16, 2022
Q1 2022
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-190K- 31.88% |
$1.44M - $4.12M
|
405K
$3.94M
|
|
|
May 16, 2022
Q1 2022
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-225K- 76.11% |
$1.71M - $4.89M
|
70.7K
$688K
|
|
|
May 16, 2022
Q1 2022
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-264K- 55.72% |
$2M - $5.74M
|
210K
$2.04M
|
|
|
May 13, 2022
Q1 2022
|
Nantahala Capital Management, LLC
New Canaan, CT |
SELL
|
- |
-296K- 4.15% |
$2.24M - $6.44M
|
6.85M
$66.6M
|
|
|
Apr 25, 2022
Q1 2022
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-540K- 92.73% |
$4.09M - $11.7M
|
42.3K
$412K
|
|
|
May 16, 2022
Q1 2022
|
Soleus Capital Management, L.P.
Greenwich, CT |
SELL
|
- |
-770KClosed |
$5.83M - $16.7M
|
0
$0
|
|
|
May 12, 2022
Q1 2022
|
Integral Health Asset Management, LLC
|
SELL
|
- |
-925K- 56.92% |
$7M - $20.1M
|
700K
$6.81M
|
|
|
May 16, 2022
Q1 2022
|
Stonepine Capital Management, LLC
Bend, OR |
SELL
|
- |
-1.51MClosed |
$11.4M - $32.8M
|
0
$0
|